FFAGLDD (TFA)

• Description :

  FFAGLDD TFA is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release[1].

• UNSPSC :

  12352209

• Target :

  MMP

• Type :

  Peptides

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/ffagldd-tfa.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=CC=C2)N.OC(C(F)(F)F)=O

• Molecular Formula :

  C39H50F3N7O14

• Molecular Weight :

  897.85

• References & Citations :

  [1]Zhou Q, et al. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine. 2018 May 18;13:2921-2942.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• Isoform :

  MMP-9